1. Li HF*, Hu SM, Lv M.Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome.JAMA.2022.327(4).392-393..SCI |
2. Li HY, Shao LY, Song M, Hu SM, Yue YX, Li HF*.Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study..Front Immunol..2022.13.923017.SCI |
3. Li HF, Gilhus NE, Yang H, Chen X.Phenotypes of myasthenia gravis..Front Neurol.2022.13.1025183.SCI |
4. Shao K, Yue YX, Zhao LM, Hao HJ, Ding XJ, Jiang P, Yan CZ, Li HF*.Optimization of the cut-offs in acetylcholine receptor antibodies and diagnostic performance in myasthenia gravis patients.Clin Chim Acta. .2022.533.122-130..SCI |
5. Yan Li HY, Jiang P, Xie Y, Liang B, Li L, Zhao CP, Yue YX, Li HF*.Criteria for Treatment Response in Myasthenia Gravis: Comparison Between Absolute Change and Improvement Percentage in Severity Scores.Front Neurol.2022.13.880040.SCI |
6. Jiang P, Li J, Li HY, Zhang B, Yue YX, Wang YS, Zi XC, Liu SS, Li YF, Jiao LD, Li HF* .Minimal Manifestation Status Indicates a Stable State in Myasthenia Gravis: A Quantitative Study.Front Neurol.2022.13.880045.SCI |
7. Hu SM, Fang XH, Li HF*.Postoperative Atrial Fibrillation After Noncardiac Surgery and Stroke..JAMA.2021.325(2).187.SCI |
8. Yue YX, Gao X, Tang TP, Xie Y, Gu CK, Hao HJ, Li HY, Ding XJ, Song M, Guo SG, Li HF*.Complement C3 polymorphism is associated with the susceptibility of myasthenia gravis in Chinese adult patients.J Neuroimmunol.2021.353.577487.SCI |
9. 李海峰.重症肌无力治疗策略的演变及个体化治疗路径.中华医学杂志.2021.101(31).2492-2496.核心期刊 |
10. Han JL, Yue YX, Gao X, Xie YC, Hao HJ, Li HY, Yu XL, Li J, Duan RS*, Li HF*.Vitamin D Receptor Polymorphism and Myasthenia Gravis in Chinese Han Population..Front Neurol.2021.12.604052.SCI |
11. Li HF*, Hao HJ, Chen XJ.Provisional case definitions for COVID-19-associated neurological disease..Lancet Neurol.2020.19(11).890-891.SCI |
12. Cai GM, Gao Z, Yue YX, Xie YC, Gao X, Hao HJ, Zhang XJ, Wang Q, Liang B, Li HF*..Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort..J Clin Neurosci..2019.69.31-37.SCI |
13. Li HF*, Liang B, Li HY .Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management..Eur Heart J..2019.40(36).3058-3059.SCI |
14. 李海峰,王琳,高翔,夏梦,张栩,杨欢,周红雨,谢琰臣,邱伟 .重症肌无力严重程度新量表的形成与信度效度评价.中华神经科杂志.2018.51(6).430-437.核心期刊 |
15. Li HF*, Hong Y.Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies..J Am Coll Cardiol..2018.72(20).2545-2546.SCI |
16. Jiang P, Yue YX, Hong Y, Xie Y, Gao X, Gu CK, Hao HJ, Qin Y, Ding XJ, Song M, Li HF*, Zhang X*..IL-4Rα Polymorphism Is Associated With Myasthenia Gravis in Chinese Han Population.Front Neurol..2018.9.529.SCI |
17. Zhang X, Ding XJ, Wang Q, Yue YX, Xie Y, Hao HJ, Liang B, Zhang XJ, Song M, Gao Z, Jiang P, Qin Y, Li HF*..Rs3761389 polymorphism in autoimmune regulator (AIRE) gene is associated with susceptibility of myasthenia gravis in Chinese patients.J Clin Neurosci..2017.40.180-184.SCI |
18. Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, Hao HJ, Gao X, Owe JF, Zhang X, Yue YX, Romi F, Wang Q, Li HF*, Gilhus NE*, Tzartos SJ*.Multiple antibody detection in “double seronegative” myasthenia gravis patients..Eur J Neurol..2017.24(6).844-850.SCI |
19. Xie Y#, Li HF*#, Sun L, Kusner LL, Wang S, Meng Y, Zhang X, Hong Y, Gao X, Li Y, Kaminski HJ*..The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis.Front Neurol..2017.8.230.SCI |
20. Li HF#*, Hong Y#, Zhang X, Xie Y, Skeie GO, Hao HJ, Gilhus NE, Liang B, Yue YX, Zhang XJ, Gao X.Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.Mol Neurobiol..2017.54(6).4771-4780.SCI |
21. 王琳,高翔,夏梦,李铁山,刘涛,张栩,梁兵,李伟,李海峰*.应用 Delphi 法结合前期条目评价建立重症肌无力严重程度新量表.中华神经科杂志.2017.50(10).730-736.核心期刊 |
22. Xie Y#, Meng Y#, Li HF#*, Hong Y, Sun L, Zhu X, Yue YX, Gao X, Wang S, Li Y, Kusner LL, Kaminski HJ..GR gene polymorphism is associated with inter-subject variability in response to glucocorticoids in patients with myasthenia gravis.Eur J Neurol..2016.23(8).1372-1379.SCI |
23. Yue YX, Hong Y, Xie Y, Hao HJ, Sui Y, Gu CK, Zhang X, Gao X, Tang TP, Zhang XJ, Wang Q, Li HF* .Association study between IL-17A and IL-17F gene polymorphism and myasthenia gravis in Chinese patients.Neurol Sci..2016.37(1).123-130.SCI |
24. 高翔,张栩,杨欢,周红雨,谢琰臣,邱伟,肖丽,王任华,夏梦,王琳,李海峰*.重症肌无力严重程度量表的评价.中华神经科杂志.2016.49(5).375-381.核心期刊 |
25. Li HF*, Xie Y, Yue YX..Myasthenia gravis: subgroup classification.Lancet Neurol. .2016.15(4).355-356.SCI |
26. Hong Y, Li HF#, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE*..Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.J Neuroimmunol..2016.298.51-57.SCI |
27. Li HF.Precision medicine in myasthenia graves: begin from the data precision..Ann Transl Med..2016.4.106.SCI |
28. Li HF*, Zhao RL..Lack of stroke subtype information may hinder indirect comparison between ROCKET-AF and other trials of new oral anticoagulants..J Am Coll Cardiol. .2013.61(5).595-596..SCI |
29. Li H, Zhang X..Oral cladribine and fingolimod for relapsing multiple sclerosis.N Engl J Med. .2010.362(18).1738-1739.SCI |
30. Li HF*, Zhang HL, Zhu J..Methodologists are not qualified to write clinical guidelines..Lancet.2009.374(9698).1326-1327.SCI |
31. Li HF*, Xie YC..Guillain-Barre syndrome. .Lancet Neurol..2008.7(12).1081-1082.SCI |
32. Li HF.Are statins analogues of vitamin D?.Lancet.2006.368(9543).1233-1234.SCI |